Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier

A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection

(2019) Amr Radwan et al.   Parasites & Vectors

Chitosan grafted into mesoporous silica nanoparticles as benznidazol carrier for Chagas diseases treatment

(2018) Egídio Paulo Francisco Nhavene et al.   MICROPOROUS AND MESOPOROUS MATERIALS

Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance

(2018) Saliu Alao Amolegbe et al.   Scientific Reports

Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting

(2018) Rokaya Amara et al.   International Journal of Nanomedicine

The toxicity of silica nanoparticles to the immune system

(2018) Liangjiao Chen et al.   Nanomedicine

Albendazole and Praziquantel Chitosan Nanoparticles: Preparation, Characterization, and In Vitro Release Study

(2017) Negin Torabi et al.   Iranian Journal of Science and Technology Transaction A-Science

Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights

(2017) María Vallet-Regí et al.   MOLECULES

In vitro schistosomicidal activity of the lignan (−)-6,6′-dinitrohinokinin (DNHK) loaded into poly(lactic-co-glycolic acid) nanoparticles against Schistosoma mansoni

(2017) Thaís C. Lima et al.   PHARMACEUTICAL BIOLOGY

Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model

(2017) Nada Abla et al.   PLoS Neglected Tropical Diseases

Effect of gold nanoparticles on mice splenomegaly induced by schistosomiasis mansoni

(2017) Mohamed A. Dkhil et al.   SAUDI JOURNAL OF BIOLOGICAL SCIENCES

Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles

(2017) Jingga Morry et al.   Redox Biology

A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics

(2017) Yating Zhao et al.   Scientific Reports

Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni

(2016) Riham M. El-Moslemany et al.   ACTA TROPICA

DLS and zeta potential – What they are and what they are not?

(2016) Sourav Bhattacharjee   JOURNAL OF CONTROLLED RELEASE

Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery

(2016) Qiang Fu et al.   Nanomedicine-Nanotechnology Biology and Medicine

Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery

(2016) Simon Heidegger et al.   Nanoscale

Development of docetaxel and alendronate-loaded chitosan-conjugated polylactide-co-glycolide nanoparticles: In vitro characterization in osteosarcoma cells

(2016) Ya-Feng Liu et al.   TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Praziquantel in a Clay Nanoformulation Shows More Bioavailability and Higher Efficacy against Murine Schistosoma mansoni Infection

(2015) Gina S. El-Feky et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Schistosomicidal, hepatoprotective and antioxidant activities of the methanolic fraction from Clerodendrum umbellatum Poir leaves aqueous extract in Schistosoma mansoni infection in mice

(2015) Hermine Boukeng Jatsa et al.   BMC Complementary and Alternative Medicine

Nanostructured Lipid Carriers as a Strategy to Improve the In Vitro Schistosomiasis Activity of Praziquantel

(2015) Fernanda Kolenyak-Santos et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study

(2015) Maha M. Eissa et al.   PLoS One

Influence of some micronutrients and Citharexylum quadrangular extract against liver fibrosis in Schistosoma mansoni infected mice

(2014) M. Kadry   African Journal of Pharmacy and Pharmacology

Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni

(2014) Naglaa Mohamed El-Lakkany et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects

(2014) Sutapa Barua et al.   Nano Today

Liposome Encapsulated Albumin-Paclitaxel Nanoparticle for Enhanced Antitumor Efficacy

(2014) Hima Bindu Ruttala et al.   PHARMACEUTICAL RESEARCH

Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers

(2014) Nihal Saad Elbialy et al.   Physica Medica-European Journal of Medical Physics

Synthesis and surface functionalization of silica nanoparticles for nanomedicine

(2014) Alexander Liberman et al.   SURFACE SCIENCE REPORTS

Engineered nanoparticles interacting with cells: size matters

(2014) Li Shang et al.   JOURNAL OF NANOBIOTECHNOLOGY

Liposomal-praziquantel: Efficacy against Schistosoma mansoni in a preclinical assay

(2013) Tarsila Ferraz Frezza et al.   ACTA TROPICA

Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research

(2013) Yi-Xiang Wang et al.   CURRENT PHARMACEUTICAL DESIGN

First insight into the effect of single oral dose therapy with artemisinin–naphthoquine phosphate combination in a mouse model of Schistosoma mansoni infection

(2013) Samar N. El-Beshbishi et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment

(2013) Ana Luiza Ribeiro de Souza et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

New approaches for understanding mechanisms of drug resistance in schistosomes

(2013) ROBERT M. GREENBERG   PARASITOLOGY

Mesoporous silica nanoparticles in medicine—Recent advances

(2012) Veronika Mamaeva et al.   ADVANCED DRUG DELIVERY REVIEWS

Mesoporous Silica Nanoparticles for Increasing the Oral Bioavailability and Permeation of Poorly Water Soluble Drugs

(2012) Yanzhuo Zhang et al.   MOLECULAR PHARMACEUTICS

Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery

(2011) Qi Gan et al.   BIOMEDICAL MICRODEVICES

Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death

(2011) Partha Mukhopadhyay et al.   FREE RADICAL BIOLOGY AND MEDICINE

Dynamic self-assembly synthesis and controlled release as drug vehicles of porous hollow silica nanoparticles

(2011) Shun Tan et al.   MICROPOROUS AND MESOPOROUS MATERIALS

Immunological and parasitological parameters after treatment with dexamethasone in murine Schistosoma mansoni

(2010) Ibrahim RB Aly et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Sandwich ELISA for quantitative detection of human collagen prolyl 4-hydroxylase

(2010) Ekaterina Osmekhina et al.   Microbial Cell Factories

Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles

(2010) Shuyu Xie et al.   Nanomedicine

Reproducible Comet Assay of Amorphous Silica Nanoparticles Detects No Genotoxicity

(2008) Clifford A. Barnes et al.   NANO LETTERS

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL